網膜障害治療の世界市場:疾患徴候別(黄斑変性、糖尿病性網膜症、糖尿病黄斑浮腫、その他(網膜静脈閉塞など))、治療クラス別(抗VEGF剤、その他(抗炎症薬など))、投与形態別(ゲル、目薬、カプセル&錠剤、点眼薬、軟膏)、流通経路別(病院薬局、小売薬局、オンライン販売)

◆英語タイトル:Global Retinal Disorder Treatment Market Size study, by Disease Indication (Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, Others (Retinal Vein Occlusion, etc.)), by Therapeutic Class (Anti-VEGF Agents, Others (Anti-inflammatory Drugs, etc.)), by Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales) and Regional Forecasts 2019-2026
◆商品コード:BZW20FB159
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年1月21日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、網膜障害治療の世界市場について調べ、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、疾患徴候別(黄斑変性、糖尿病性網膜症、糖尿病黄斑浮腫、その他(網膜静脈閉塞など))分析、治療クラス別(抗VEGF剤、その他(抗炎症薬など))分析、投与形態別(ゲル、目薬、カプセル&錠剤、点眼薬、軟膏)分析、流通経路別(病院薬局、小売薬局、オンライン販売)分析、地域別分析、競争状況などで構成されています。
・エグゼクティブサマリー
・市場の定義・範囲
・市場動向
・産業分析
・網膜障害治療の世界市場:疾患徴候別(黄斑変性、糖尿病性網膜症、糖尿病黄斑浮腫、その他(網膜静脈閉塞など))
・網膜障害治療の世界市場:治療クラス別(抗VEGF剤、その他(抗炎症薬など))
・網膜障害治療の世界市場:投与形態別(ゲル、目薬、カプセル&錠剤、点眼薬、軟膏)
・網膜障害治療の世界市場:流通経路別(病院薬局、小売薬局、オンライン販売)
・網膜障害治療の世界市場:地域別
・競争状況
【レポートの概要】

Global Retinal Disorder Treatment Market is valued approximately at USD 8.73 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.10% over the forecast period 2019-2026. Retina is a thin membranous lining at the back of the eye. It is a light sensitive nerve tissue on which the images focused and converted into electrical impulses which are carried to the brain via optic nerve. Retinal disorders affect the important tissues of the eye and can even cause temporary to permanent blindness. According to World Health Organization 2019, over 295 million people are visually impaired worldwide of which 39 million are blind. Further, retinal diseases are the most common cause of childhood blindness across the globe. Some of these children are blinded by inherited retinal diseases (IRD) like retinitis pigmentosa (incurable) while many of them can have retinopathy of prematurity (curable). Growing retinal diseases worldwide calls for the need of affordable and effective treatment alternatives which in turn will drive the global retinal disorder treatment market. Also, technical advancements, new product launches, collaborations and other strategies being executed by the major players is anticipated to provide low cost and effective retinal disorder treatment and hence fuel the market growth. Moreover, government and other nonprofit organizations are increasing spending on the treatment of retinal disorder treatments. For instance, The Foundation Fighting Blindness, a nonprofit organization established on 1971, is leading a collaborative effort among scientists, patients, their families and the commercial sector to propel the development of preventions, treatments, and cures for inherited retinal diseases (IRDs). Therefore, rising awareness, collaborative efforts and initiatives by the key players are the factors likely to create growth opportunities to the retinal disorder treatment market over the forecast period.

The regional analysis of global Retinal Disorder Treatment Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of key market players in the region. Also, increasing prevalence of retinal disorders is expected to fuel the regional growth. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising awareness about early diagnosis, high unmet clinical needs and availability of effective treatment methods are responsible for the high CAGR of the region over the forecast period.

Major market player included in this report are:
Santen Pharmaceutical Co., Ltd.
Regeneron Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Allergan plc
Shire (Takeda Pharmaceutical Company Limited)
Bayer AG
Graybug Vision, Inc.
Novartis AG
Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Indication:
Macular Degeneration
Diabetic Retinopathy
Diabetic Macular Edema
Others (Retinal Vein Occlusion, etc.)

By Therapeutic Class:
Anti-VEGF Agents
Others (Anti-inflammatory Drugs, etc.)

By Dosage Form:
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Sales

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Retinal Disorder Treatment Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Retinal Disorder Treatment Market, by Disease Indication, 2017-2026 (USD Billion)
1.2.2. Retinal Disorder Treatment Market, by Therapeutic Class, 2017-2026 (USD Billion)
1.2.3. Retinal Disorder Treatment Market, by Dosage Form, 2017-2026 (USD Billion)
1.2.4. Retinal Disorder Treatment Market, by Distribution Channel, 2017-2026 (USD Billion)
1.2.5. Retinal Disorder Treatment Market, by Region, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Retinal Disorder Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Retinal Disorder Treatment Market Dynamics
3.1. Retinal Disorder Treatment Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Retinal Disorder Treatment Market Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Retinal Disorder Treatment Market, by Disease Indication
5.1. Market Snapshot
5.2. Global Retinal Disorder Treatment Market by Disease Indication, Performance – Potential Analysis
5.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Disease Indication 2016-2026 (USD Billion)
5.4. Retinal Disorder Treatment Market, Sub Segment Analysis
5.4.1. Macular Degeneration
5.4.2. Diabetic Retinopathy
5.4.3. Diabetic Macular Edema
5.4.4. Others (Retinal Vein Occlusion, etc.)
Chapter 6. Global Retinal Disorder Treatment Market, by Therapeutic Class
6.1. Market Snapshot
6.2. Global Retinal Disorder Treatment Market by Therapeutic Class, Performance – Potential Analysis
6.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Therapeutic Class, 2016-2026 (USD Billion)
6.4. Retinal Disorder Treatment Market, Sub Segment Analysis
6.4.1. Anti-VEGF Agents
6.4.2. Others (Anti-inflammatory Drugs, etc.)
Chapter 7. Global Retinal Disorder Treatment Market, by Dosage Form
7.1. Market Snapshot
7.2. Global Retinal Disorder Treatment Market by Dosage Form, Performance – Potential Analysis
7.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Dosage Form, 2016-2026 (USD Billion)
7.4. Retinal Disorder Treatment Market, Sub Segment Analysis
7.4.1. Gels
7.4.2. Eye Solutions
7.4.3. Capsules & Tablets
7.4.4. Eye Drops
7.4.5. Ointments
Chapter 8. Global Retinal Disorder Treatment Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Retinal Disorder Treatment Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Retinal Disorder Treatment Market Estimates & Forecasts by Distribution Channel, 2016-2026 (USD Billion)
8.4. Retinal Disorder Treatment Market, Sub Segment Analysis
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Sales
Chapter 9. Global Retinal Disorder Treatment Market, Regional Analysis
9.1. Retinal Disorder Treatment Market, Regional Market Snapshot
9.2. North America Retinal Disorder Treatment Market
9.2.1. U.S. Retinal Disorder Treatment Market
9.2.1.1. Disease Indication breakdown estimates & forecasts, 2016-2026
9.2.1.2. Therapeutic Class breakdown estimates & forecasts, 2016-2026
9.2.1.3. Dosage Form breakdown estimates & forecasts, 2016-2026
9.2.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Retinal Disorder Treatment Market
9.3. Europe Retinal Disorder Treatment Market Snapshot
9.3.1. U.K. Retinal Disorder Treatment Market
9.3.2. Germany Retinal Disorder Treatment Market
9.3.3. Rest of Europe Retinal Disorder Treatment Market
9.4. Asia-Pacific Retinal Disorder Treatment Market Snapshot
9.4.1. China Retinal Disorder Treatment Market
9.4.2. India Retinal Disorder Treatment Market
9.4.3. Japan Retinal Disorder Treatment Market
9.4.4. Rest of Asia Pacific Retinal Disorder Treatment Market
9.5. Latin America Retinal Disorder Treatment Market Snapshot
9.5.1. Brazil Retinal Disorder Treatment Market
9.5.2. Mexico Retinal Disorder Treatment Market
9.6. Rest of The World Retinal Disorder Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Santen Pharmaceutical Co., Ltd.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject To Data Availability)
10.2.1.4. Sensor Type Summary
10.2.1.5. Recent Developments
10.2.2. Regeneron Pharmaceuticals, Inc.
10.2.3. F. Hoffmann-La Roche Ltd.
10.2.4. Pfizer, Inc.
10.2.5. Allergan plc
10.2.6. Shire (Takeda Pharmaceutical Company Limited)
10.2.7. Bayer AG
10.2.8. Graybug Vision, Inc.
10.2.9. Novartis AG
10.2.10. Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

List of Tables
TABLE 1. LIST OF SECONDARY EQUIPMENT TYPES, USED IN THE STUDY OF GLOBAL RETINAL DISORDER TREATMENT MARKET
TABLE 2. LIST OF PRIMARY EQUIPMENT TYPES, USED IN THE STUDY OF GLOBAL RETINAL DISORDER TREATMENT MARKET
TABLE 3. GLOBAL RETINAL DISORDER TREATMENT MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DISEASE INDICATION 2016-2026 (USD BILLION)
TABLE 8. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY THERAPEUTIC CLASS 2016-2026 (USD BILLION)
TABLE 9. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DOSAGE FORM 2016-2026 (USD BILLION)
TABLE 10. GLOBAL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2016-2026 (USD BILLION)
TABLE 11. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. GLOBAL RETINAL DISORDER TREATMENT MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. GLOBAL RETINAL DISORDER TREATMENT MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. U.S. RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. CANADA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. UK RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. GERMANY RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. ROE RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. CHINA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. INDIA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. JAPAN RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. ROAPAC RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. BRAZIL RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. MEXICO RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 59. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60. ROLA RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 61. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 62. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63. ROW RETINAL DISORDER TREATMENT MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[網膜障害治療の世界市場:疾患徴候別(黄斑変性、糖尿病性網膜症、糖尿病黄斑浮腫、その他(網膜静脈閉塞など))、治療クラス別(抗VEGF剤、その他(抗炎症薬など))、投与形態別(ゲル、目薬、カプセル&錠剤、点眼薬、軟膏)、流通経路別(病院薬局、小売薬局、オンライン販売)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆